We recently compiled a list of the 10 Hottest Mid-Cap Stocks So Far in 2025. In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against the other mid-cap ...

Stryker is now opening its pocketbook a bit wider to acquire Inari Medical with its portfolio of blood-clot-busting devices and 1,400 employees. Stryker will put down $80 per share in cash for ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

Inari’s portfolio of medical devices and accessories to treat venous thromboembolism (VTE), or blood clots in the veins, was highly attractive to Stryker, according to Inari Chief Executive Drew Hykes ...

On Tuesday, Inari Medical Inc (NARI) stock saw a decline, ending the day at $79.5 which represents a decrease of $-0.05 or -0.06% from the prior close of $79.55. The stock opened at $79.54 and touched ...

Investing.com -- Inari Medical Inc (NASDAQ ... a condition where blood clots form in veins, as well as other vascular diseases. Stryker will pay $80 per share for Inari, as initially reported ...

Inari Medical (NASDAQ:NARI) makes medical devices. These devices are mostly used to treat blot clots in veins. Inari Medical is what I discussed before in an article talking about mid-cap stocks.

1 Inari provides solutions for VTE clot removal without the use of thrombolytic ... About Stryker Stryker is a global leader in medical technologies and, together with its customers, is driven ...

NEW YORK, Jan 6 (Reuters) - Medical-device maker Stryker (SYK.N), opens new tab on Monday agreed to acquire Inari Medical ... where a blood clot forms in a vein, and other vascular diseases.

Inari Medical (NASDAQ:NARI – Free Report ... capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large ...